Breaking News

Paladin Expands OTC Portfolio

October 19, 2012

Gains rights to cold sore product in Canada

Paladin Labs has entered into a licensing and distribution agreement with Dynamiclear Australia, under which Paladin receives the exclusive rights to market and sell cold sore treatment Dynamiclear Rapid in Canada. Paladin also received an option to acquire rights to Dynamiclear’s antiviral formulation for Herpes Simplex Virus-2 infections, which is currently under development. Financial terms were not disclosed.
“We are pleased to add Dynamiclear Rapid to our OTC portfolio. Cold sores are one of the most common viral diseases in humans. We believe that Canadian sufferers will prefer Dynamiclear Rapid for the convenience of its single application treatment as well as the speed and efficacy of the relief it delivers,” said Mark Beaudet, interim president and chief executive officer of Paladin. “Dynamiclear Rapid will complement our growing OTC business, which already includes well known consumer brands like Plan B, Tempra, and Zincofax.”
“We are very excited to partner with Paladin in Canada,” said Dr. John Spurge, executive director of Dynamiclear. “This is a major event for Dynamiclear and we have confidence in the market potential of Dynamiclear Rapid in Canada given the continued strong sales in Australia. Paladin has a proven track record and the ability to maximize the commercial potential of Dynamiclear Rapid.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks